193
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

Gambogenic acid inhibits proliferation of A549 cells through apoptosis inducing through up-regulation of the p38 MAPK cascade

, , , , , , & show all
Pages 993-1002 | Received 16 Mar 2011, Accepted 11 Jul 2011, Published online: 19 Oct 2011
 

Abstract

Gamboge is a dry resin secreted from Garcinia hanburryi, and gambogenic acid (GNA) is one of the main active compounds of gamboge. We have previously demonstrated the anticancer activity of GNA in A549 cells and pointed out its potential effects in anticancer therapies. Previous studies reported that GNA induced apoptosis in many cancer cell lines and inhibited A549 tumor growth in xenograft of nude mice in vivo. However, the anticancer mechanism of GNA has still not been well studied. In this paper, we have investigated whether GNA-induced apoptosis is critically mediated by the p38 mitogen-activated protein kinase (MAPK) pathway. Our findings revealed that GNA could induce apoptosis, inhibit proliferation, down-regulate the expression of p38 and MAPK, increase the activations of caspase-9, caspase-3, and cytochrome c release. Furthermore, using SB203580, an adenosine triphosphate-competitive inhibitor of p38 MAPK, inhibit the expression of p-p38 and the experimental results show that it may promote the occurrence of apoptosis induced by GNA. Taken together, these results suggested that up-regulation of the p38 MAPK cascade may account for the activation of GNA-induced apoptosis.

Acknowledgements

This study was financially supported by Key Projects in the National Science & Technology Pillar Program during the 11th five-year plan period 2009ZX09103-399 (Q. Li, co-PI) and the Natural Sciences Funding of Anhui Province (11040606M190), China and supported by Key Laboratory of Traditional Chinese Medicine Resource and Compound Prescription (HUCM), Ministry of Education.

Notes

1 These authors contributed equally to this work.

Additional information

Notes on contributors

Hui Cheng

1

Jing-Jing Su

1

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.